Fredag 27 Februari | 23:48:40 Europe / Stockholm

Bifogade filer

Kalender

Est. tid*
2027-02-16 N/A Bokslutskommuniké 2026
2026-11-17 08:00 Kvartalsrapport 2026-Q3
2026-08-18 08:00 Kvartalsrapport 2026-Q2
2026-06-08 N/A X-dag ordinarie utdelning POLYMER 0.00 SEK
2026-06-05 N/A Årsstämma
2026-05-15 08:00 Kvartalsrapport 2026-Q1
2026-03-10 N/A Extra Bolagsstämma 2025
2026-02-17 - Bokslutskommuniké 2025
2025-11-14 - Kvartalsrapport 2025-Q3
2025-08-15 - Kvartalsrapport 2025-Q2
2025-06-04 - X-dag ordinarie utdelning POLYMER 0.00 SEK
2025-06-03 - Årsstämma
2025-05-16 - Kvartalsrapport 2025-Q1
2025-02-26 - Extra Bolagsstämma 2024
2025-02-17 - Bokslutskommuniké 2024
2024-11-08 - Kvartalsrapport 2024-Q3
2024-08-16 - Kvartalsrapport 2024-Q2
2024-06-07 - X-dag ordinarie utdelning POLYMER 0.00 SEK
2024-06-05 - Årsstämma
2024-05-08 - Kvartalsrapport 2024-Q1
2024-02-16 - Bokslutskommuniké 2023
2023-11-10 - Kvartalsrapport 2023-Q3
2023-08-16 - Kvartalsrapport 2023-Q2
2023-06-05 - X-dag ordinarie utdelning POLYMER 0.00 SEK
2023-06-02 - Årsstämma
2023-05-10 - Kvartalsrapport 2023-Q1
2023-02-15 - Extra Bolagsstämma 2023
2023-02-10 - Bokslutskommuniké 2022
2022-11-10 - Kvartalsrapport 2022-Q3
2022-08-10 - Kvartalsrapport 2022-Q2
2022-06-09 - X-dag ordinarie utdelning POLYMER 0.00 SEK
2022-06-08 - Årsstämma
2022-05-10 - Kvartalsrapport 2022-Q1
2022-02-25 - Bokslutskommuniké 2021
2021-12-20 - Extra Bolagsstämma 2021
2021-11-25 - Kvartalsrapport 2021-Q3
2021-08-25 - Kvartalsrapport 2021-Q2
2021-06-03 - Årsstämma
2021-05-25 - Kvartalsrapport 2021-Q1

Beskrivning

LandSverige
ListaNordic SME Sweden
SektorMaterial
IndustriPlast, kemikalier & fetter
Polymer Factory Sweden är specialiserat inom nanoteknologi. Bolaget utvecklar polymera material som används i diverse medicinska behandlingar. Lösningarna används huvudsakligen som komplement i olika behandlingar för cancer och neurologiska sjukdomar. Utöver huvudverksamheten erbjuder bolaget kalibreringsteknik som används i olika analyser- och livsmedelstestning.

Intresserad av bolagets nyckeltal?

Analysera bolaget i Börsdata!

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

2026-02-17 08:00:00

Fourth quarter, October-December 2025

  • Polymer Factory Launches Sales Hub in the United States in cooperation with Labscoop
  • Polymer Factory decided to terminate liquidity guarantee for the company's shares

Comments from CEO Mats Wallnér
Polymer Factory has all the key components in place and a well-structured organization that enables
multiple commercial partnerships.

"Net sales for the full year 2025 increased by 18%, while operating expenses decreased by 10% compared with 2024"

Increased Sales and Reduced Costs
Net sales for the full year 2025 increased by 18%, while operating expenses decreased by 10% compared with 2024. The Company continues to report a negative result; however, operating profit for 2025 improved by 30% year-on-year. Polymer Factory benefits from an exceptionally high gross margin, providing increased financial flexibility as revenues grow. Overall, the financial figures demonstrate a positive trend and confirm that the Company is moving in the right direction.

Growth Strategy Through Partnerships and Direct Sales
Polymer Factory's unique products are purchased by customers across multiple industries, primarily in the United States and Europe, while interest from customers in Asia is also increasing. Partnerships and direct sales play complementary roles in the Company's growth strategy. Integration with Bruker and its competitors provides global reach within mass spectrometry, while partners such as Merck, Labscoop, AMR, and others offer scalable access to research customers worldwide. Direct sales enable Polymer Factory to build close customer relationships, gain application insights, and identify new needs. Partnerships drive volume and validation, while direct sales drive insight and margins.

Focus Plan to Achieve Positive Cash Flow
The Company emphasizes organic growth, high-margin products, and a cost-efficient operating model. Partnerships enable scaling without corresponding increases in costs, thereby improving cash flow. Positive free cash flow will be driven by increased revenues from premium segments, stronger customer penetration in North America and Europe, and expanded direct sales. Polymer Factory also utilizes selective project financing and non-dilutive funding. The strategy is built on profitable segments, scalable distribution, and disciplined cost control.

Increased External Uncertainty
There continues to be a heightened level of uncertainty in the global environment, driven by complex geopolitical conditions, significant uncertainty surrounding tariffs and trade, high asset prices, and the risk of persistently sluggish inflation. Despite a volatile external environment, I remain optimistic about Polymer Factory's development during 2026. Capital markets for IPOs are beginning to thaw after several challenging years. The global companies with which we have commercial relationships value the customer benefits delivered by our products, as well as the expertise and deep technical knowledge within the Company. We enter 2026 with strengthened confidence, several strategic collaborations in place, and a continued focus on growth and profitability.

This disclosure contains information that Polymer Factory is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 17-02-2026 08:00 CET.